Sionna Therapeutics, Inc. (SION) earnings
SION earnings moved a median of +3.37% by the close. Quarterly and annual SION reports and results, each read against the price at its own news timestamp. Back to the SION overview →
12 measured SION earnings events.
Where these SION earnings landedvs 12 measured SION earnings reactions
| Middle 50% of SION earnings reactions | -1.52% to +5.31% |
|---|---|
| Median reaction (to close) | +3.37% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 SION earnings events with a measured close landed between -1.52% and +5.31%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Sionna Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.20% | +5.31% | |
| Sionna Therapeutics Reports Second Quarter 2026 Financial Results | Press release | +1.20% | +5.31% | |
| Form 10-Q Sionna Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -5.04% | -9.16% | |
| Sionna Therapeutics Reports First Quarter 2026 Financial Results | Press release | -5.04% | -9.16% | |
| Form 10-K Sionna Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.25% | +3.13% | |
| Form 10-Q Sionna Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.32% | |
| Sionna Therapeutics Reports Third Quarter 2025 Financial Results | Press release | +0.00% | -1.32% | |
| Form 10-Q Sionna Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.92% | +7.63% | |
| Sionna Therapeutics Reports Second Quarter 2025 Financial Results | Press release | -3.92% | +7.63% | |
| Form 10-Q Sionna Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.05% | +3.61% | |
| Sionna Therapeutics Reports First Quarter 2025 Financial Results | Press release | +2.05% | +3.61% | |
| Form 10-K Sionna Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.62% | -2.12% |
Keep exploring
More SION: analyst actions → · SEC filings → · SION overview →